BACKGROUND: We determined staff radiation dose during rest and stress rubidium 82 myocardial perfusion positron emission tomography (PET) imaging. METHODS AND RESULTS: Patients received 1,587 +/- 163 MBq (42.9 +/- 4.4 mCi) Rb-82 during rest or pharmacologic stress. A pressurized ion chamber was used to monitor radiation exposure in 50 examinations. For comparison, staff exposure during pharmacologic stress in 20 other patients receiving 1,204 +/- 55.5 MBq (32.54 +/- 1.5 mCi) technetium 99m 2-methoxy isobutyl isonitrile (MIBI) was measured. For Rb-82 infusion and PET acquisition, the mean dose was 0.45 +/- 0.25 microSv (0.045 +/- 0.025 mrem). Exposure for routine stress testing at variable distances from the patient was equivalent to background. Similar exposure for pharmacologic stress testing through 7 minutes after injection of Tc-99m MIBI at variable distances was 1.075 +/- 0.32 microSv (0.108 +/- 0.03 mrem). However, exposure for stress tests starting 7 minutes after Rb-82 infusion at 0.5 m was estimated at 0.4 microSv (0.04 mrem). To determine the potential radiation dose for those responding to a medical emergency or otherwise in close proximity to a patient, we measured the mean cumulative dose at 0.5 m from 0 to 7 minutes of Rb-82 infusion, which resulted in 19.1 +/- 5.8 microSv (1.9 +/- 0.58 mrem). CONCLUSIONS: Radiation doses for all tasks during routine Rb-82 stress-rest PET are lower than measured Tc-99m MIBI values. However, the radiation dose in close proximity to the patient during or immediately after Rb-82 infusion can be considerably higher, underscoring the need for strict attention to source distance and contact times.
BACKGROUND: We determined staff radiation dose during rest and stress rubidium 82 myocardial perfusion positron emission tomography (PET) imaging. METHODS AND RESULTS:Patients received 1,587 +/- 163 MBq (42.9 +/- 4.4 mCi) Rb-82 during rest or pharmacologic stress. A pressurized ion chamber was used to monitor radiation exposure in 50 examinations. For comparison, staff exposure during pharmacologic stress in 20 other patients receiving 1,204 +/- 55.5 MBq (32.54 +/- 1.5 mCi) technetium 99m 2-methoxy isobutyl isonitrile (MIBI) was measured. For Rb-82 infusion and PET acquisition, the mean dose was 0.45 +/- 0.25 microSv (0.045 +/- 0.025 mrem). Exposure for routine stress testing at variable distances from the patient was equivalent to background. Similar exposure for pharmacologic stress testing through 7 minutes after injection of Tc-99m MIBI at variable distances was 1.075 +/- 0.32 microSv (0.108 +/- 0.03 mrem). However, exposure for stress tests starting 7 minutes after Rb-82 infusion at 0.5 m was estimated at 0.4 microSv (0.04 mrem). To determine the potential radiation dose for those responding to a medical emergency or otherwise in close proximity to a patient, we measured the mean cumulative dose at 0.5 m from 0 to 7 minutes of Rb-82 infusion, which resulted in 19.1 +/- 5.8 microSv (1.9 +/- 0.58 mrem). CONCLUSIONS: Radiation doses for all tasks during routine Rb-82 stress-rest PET are lower than measured Tc-99m MIBI values. However, the radiation dose in close proximity to the patient during or immediately after Rb-82 infusion can be considerably higher, underscoring the need for strict attention to source distance and contact times.
Authors: Fiona O Roberts; Dishan H Gunawardana; Kunthi Pathmaraj; Anthony Wallace; Paul L U; Tian Mi; Sam U Berlangieri; Graeme J O'Keefe; Chris C Rowe; Andrew M Scott Journal: J Nucl Med Technol Date: 2005-03
Authors: M C Limacher; P S Douglas; G Germano; W K Laskey; B D Lindsay; M H McKetty; M E Moore; J K Park; F M Prigent; M N Walsh Journal: J Am Coll Cardiol Date: 1998-03-15 Impact factor: 24.094
Authors: C Chiesa; V De Sanctis; F Crippa; M Schiavini; C E Fraigola; A Bogni; C Pascali; D Decise; R Marchesini; E Bombardieri Journal: Eur J Nucl Med Date: 1997-11
Authors: John O Prior; Gilles Allenbach; Ines Valenta; Marek Kosinski; Cyrill Burger; Francis R Verdun; Angelika Bischof Delaloye; Philipp A Kaufmann Journal: Eur J Nucl Med Mol Imaging Date: 2012-03-08 Impact factor: 9.236
Authors: Albert Flotats; Juhani Knuuti; Matthias Gutberlet; Claudio Marcassa; Frank M Bengel; Philippe A Kaufmann; Michael R Rees; Birger Hesse Journal: Eur J Nucl Med Mol Imaging Date: 2011-01 Impact factor: 9.236
Authors: Ashley M Groves; Marie-Elsya Speechly-Dick; John C Dickson; Irfan Kayani; Raymondo Endozo; Patty Blanchard; Manu Shastry; Elizabeth Prvulovich; Wendy A Waddington; Simona Ben-Haim; Jamshed B Bomanji; Jean R McEwan; Peter J Ell Journal: Eur J Nucl Med Mol Imaging Date: 2007-08-31 Impact factor: 9.236